MACK ANTHONY P. (Chief Executive Officer) purchased 16.6% of their position (25.13K shares) of VIRPAX PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $100.2K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/22/2021ACC: 0000905718-21-001521
DirectorOfficer· Chief Executive Officer
Since Feb 2021
+25.13K
Net shares
Net buyer
$100.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
25.13K acquired
Non-Derivative Transactions1
Common Stock, $0.00001 par value
Direct
Shares
+25.13K
Price / share
$3.99
Trade value
$100.25K
% of position
16.6%
11/18/2021
151.69K→176.81K
Total
Net shares
+25.13K
Net value
$100.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.00001 par value Direct | 11/18/2021 | P · Purchase | +25.13K | $3.99 | $100.25K | 16.6% | 151.69K | 176.81K |
| Total | +25.13K | $100.25K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock, $0.00001 par value
IndirectShares owned2.73M
Total
2.73M indirect2.73M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.00001 par value | 2.73M | Indirect |
| Total | 2.73M | 2.73M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported